A qualitative study evaluating COVID-19 vaccine hesitancy among individuals living in Mississippi.

Autor:	Leigland A; Department of Psychiatry, Rhode Island Hospital, Providence, RI 02903, USA., Arnold T; Department of Psychiatry, Rhode Island Hospital, Providence, RI 02903, USA.; Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA., Giorlando KK; Department of Psychiatry, Rhode Island Hospital, Providence, RI 02903, USA., Barnett AP; Department of Psychiatry, Rhode Island Hospital, Providence, RI 02903, USA.; Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA., Sims-Gomillia CE; Department of Population Health Science, University of Mississippi Medical Center, Jackson, MS 39216, USA., Bertone Z; Department of Psychiatry, Rhode Island Hospital, Providence, RI 02903, USA., Edet PP; Department of Population Health Science, University of Mississippi Medical Center, Jackson, MS 39216, USA., Whiteley L; Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA., Brown LK; Department of Psychiatry, Rhode Island Hospital, Providence, RI 02903, USA.; Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Jazyk:	angličtina
Zdroj:	SSM. Qualitative research in health [SSM Qual Res Health] 2024 Jun; Vol. 5. Date of Electronic Publication: 2023 Dec 19.
DOI:	10.1016/j.ssmqr.2023.100377
Abstrakt:	Background: COVID-19 vaccination rates are lower in the Southern United States compared to other regions. This study investigated COVID-19 vaccination hesitancy in Mississippi (MS) to identify preferences that may boost MS vaccination strategies in areas with poor vaccine uptake. Methods: Qualitative interviews were completed between April 2021 and January 2022 with staff and patients at four Federally Qualified Health Centers in MS. Interviews included the following COVID-19 vaccine topics: willingness to be vaccinated, barriers and facilitators, and methods for providing vaccine information. Data were organized with NVivo software and analyzed using reflexive thematic analysis. Results: Fifteen clinic staff and 49 patients were interviewed. Barriers to vaccine uptake included a lack of knowledge and understanding of how the vaccine worked, distrust of the government, fear of side effects, and social pressure to stay unvaccinated. Vaccination facilitators included its widespread accessibility, a desire to protect themselves and vulnerable populations, and a previous unpleasant COVID-19 illness experience. Participants stated that vaccine information should be provided by health organizations and familiar, respected community members. Conclusions: Results identified barriers to vaccination, such as mistrust of the government and healthcare system, and facilitators like vaccination advocacy originating from congregations and religious leaders. These findings can inform future COVID-19 vaccination efforts to increase overall immunization rates in MS. Future research in other locations could further assess commonalities and differences in the barriers and facilitators to vaccination. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu